May is Bladder Cancer Awareness Month 2025

Every year, over 610,000 people are diagnosed with bladder cancer around the world, and more than 1.9 million people are living with and beyond bladder cancer. Bladder cancer is the 9th most commonly diagnosed cancer, and the 6th most common among men.

Bladder Cancer Awareness Month (BCAM) is a time for those affected by bladder cancer to stand together and raise awareness of the disease while working to better support its early detection, treatment and care.

How to Get Involved in Bladder Cancer Awareness Month

In the United States, the Bladder Cancer Advocacy Network (BCAN) plays a leading role coordinating fundraising events and educational initiatives. This includes their annual Walk to End Cancer, a national event bringing thousands together across the country to raise money for bladder cancer research and care. To complement events throughout the month, BCAN provide patients, caregivers and the medical community with a library of print and online resources designed to help navigate the bladder cancer journey.

Globally, the World Bladder Cancer Patient Coalition (WBCPC) helps to drive activity in May, centered around their “Feeling Unsure? Get Checked” campaign which aims to spark conversations that raise awareness of the disease by highlighting symptoms and overcoming barriers to seeking medical advice. In support of the campaign, WBCPC provide a range of shareable digital and print resources.

Here are some of the ways you can get involved in Bladder Cancer Awareness Month during May:

Download, personalize, and share a BCAM marketing toolkit

The WBCPC BCAM toolkit contains a range of useful assets for use across social media including templates, messaging, graphics and infographics. You can download it here. Bladder cancer patient organisations around the world are likely to be sharing toolkits too - check out our list below.

Take part in an event

Browse our list of global patient organisations and find a local event.

Show your support by wearing orange

Orange is the official color of Bladder Cancer Awareness Month.

Educate yourself and others

Explore and share useful articles and resources. See our list of leading bladder cancer information platforms below. We also provide a number of articles for patients and caregivers on our blog.
Watch an expert video. You can check out the Bladder Cancer Advocacy Network's (BCAN's) library here. Their YouTube channel is another great resource.

Share your story

Share your bladder cancer story. Engage with others who are sharing theirs.
Join an online bladder cancer community, e.g. BCAN Inspire platform, Smart Patients or The American Bladder Cancer Society’s Forum.

Help raise awareness

Get involved. In keeping with the theme of the month, help spread the word by sharing a campaign message, video or infographic on social media using a campaign hashtag like #BCAM25, #BladderCancerMonth25, or #BladderCancerAwarenessMonth. Search the hashtags on your favourite social media platform to see what others have been sharing.
Follow key organisations like the World Bladder Cancer Patient Coalition, BCAN, and Beat Bladder Cancer Australia on social media (see our list below) and join the conversation.

Donate

Donate to bladder cancer research and care

Our Message to Surveillance Patients in May: Stay on Track

Patients that have been treated for non-muscle invasive bladder cancer (NMIBC) have unique monitoring needs to protect against the threat of recurrence which can be as high as 70-80%. After assessing a patient’s risk profile, doctors will recommend a regular ongoing schedule of cystoscopies to examine the inside of the bladder and urethra.

To reduce the risk of an undetected spread of disease, we're urging NMIBC patients being monitored for recurrent disease to stay on track and keep up with scheduled surveillance check-ups.

Recent American Urological Association (AUA) Registry Data suggests that the average length of follow-up monitoring among NMIBC patients is 1.8 years. This contrasts with the 5 year AUA guideline recommendation for low risk patients and the ongoing surveillance recommendation for those that are considered mid and high risk.

While the reasons for discontinuing surveillance or choosing to avoid scheduled checks may vary by individual, we know from recent patient survey data that invasive cystoscopies are a source of significant discomfort, pain, embarrassment and anxiety for many. It's likely that this is impacting compliance.

To help ease the burden of invasive testing, we provide Cxbladder Monitor, a genomic urine test that can safely reduce the frequency of cystoscopy required in patients being monitored for recurrent non-muscle invasive bladder cancer.

With this in mind, our “Stay on track” messaging speaks to NMIBC surveillance patients and suggests they consider Cxbladder Monitor as a non-invasive test alternative to help them keep up with their scheduled checks.

Learn more about Cxbladder

Stay on track with Cxbladder Monitor

Increasing Awareness of the Disease

Education is an important element of Bladder Cancer Awareness Month, both in respect to self-learning and in sharing information and resources with others.

To promote greater awareness of the disease, we recommend the following online resources:

If You're Concerned About Bladder Cancer, Ask Your Doctor About Cxbladder

Cxbladder is a suite of non-invasive genomic urine tests optimized to help rule out urothelial bladder cancer in patients experiencing microhematuria* and in those being monitored for recurrent non-muscle invasive bladder cancer.

Cxbladder tests deliver exceptional performance and clinically actionable results, reducing the need for further invasive procedures, when patients are at a low risk of disease.
Learn more about Cxbladder Contact us for more information

* Blood in urine revealed via testing and not visible to the naked eye.